Akero Therapeutics Inc (NASDAQ:AKRO) currently has a daily average trading volume of 1.36M but it saw 999177 shares traded in last market. With a market cap of 3.61B USD, the company’s current market price of $45.32 came falling about -1.48 while comparing to the previous closing price of $46.00. In past 52 weeks, the stock remained buoying in the range of price level as high as $58.40 and as low as $17.86. In the recent trading on the day, stock has struck highest price mark of $45.24 while lowest mark touched by it was $46.62.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BofA Securities which upgraded the stock as “Buy” in its note to investors issued on January 30, 2025, recommending a price target of between $35 and $63 for it. Citigroup issued its recommendations for the stock as it initiated the price target for the stock is $65.
Over the week, AKRO’s stock price is moving -4.73% down while it is 7.47% when we observe its performance for the past one month. Year-to-date it is 62.90% up and over the past year, the stock is showing an upside performance of 139.66%.
Currently, Akero Therapeutics Inc’s total number of outstanding shares is 79.67M with 1.38% of that held by the insiders while 109.29% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -24.21% and return on equity (ROE) at -27.92%. Stock’s beta reads -0.20. Stock has a price to book (P/B) ratio of 3.33. Its return on asset (ROA) is -26.06% on average.
